PRA Health Sciences, a leading clinical research organization, has agreed to acquire Symphony Health Solutions, a privately-held best-in-class provider of data, analytics and consulting solutions to the life sciences market for $530m. The acquisition reflects PRA’s commitment to a more agile, flexible and adaptive future of clinical development in which technology allows research to integrate seamlessly into patients’ daily lives. It also supports PRA’s commitment to provide deep, data-driven insights to optimize global clinical studies and drug commercialization from concept to compound to cure. “Symphony Health will also provide us with rich data insights that will allow us to customize our clinical studies to be as unique as the patients who they are designed around. By creatively harnessing the power of our technology and data assets, we are redefining the clinical development process for a more patient-centric future.” Colin Shannon, PRA’s Chief Executive Officer.